end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsPayableCurrentAndNoncurrent,AccountsPayableRelatedPartiesCurrent,AccountsPayableTradeCurrentAndNoncurrent,AccruedLiabilitiesCurrent,AdditionalPaidInCapital,AllocatedShareBasedCompensationExpense,AmortizationOfDebtDiscountPremium,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CapitalizationLongtermDebtAndEquity,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConversionOfStockSharesConverted1,ConversionOfStockSharesIssued1,ConvertibleNotesPayableCurrent,DebtInstrumentIncreaseAccruedInterest,DeferredIncomeTaxExpenseBenefit,DeferredOfferingCosts,EarningsPerShareBasicAndDiluted,EmployeeBenefitsAndShareBasedCompensation,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsReceivableRelatedParties,IncreaseDecreaseInDeferredCharges,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInDueFromRelatedParties,IncreaseDecreaseInPrepaidExpensesOther,InterestExpense,IssuanceOfStockAndWarrantsForServicesOrClaims,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LoansPayableCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OtherExpenses,OtherPrepaidExpenseCurrent,OtherResearchAndDevelopmentExpense,PaidInKindInterest,PaymentsForRepurchaseOfWarrants,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfOtherLongTermDebt,ProceedsFromIssuanceOfWarrants,ProceedsFromShortTermDebt,ProceedsFromStockOptionsExercised,ProfitLoss,RepaymentsOfOtherShortTermDebt,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted,ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance,SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1,SharePrice,SharesIssued,SharesIssuedPricePerShare,StockholdersEquity,StockIssued1,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodSharesOther,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2021-06-30,2021-08-16,10-Q,"Unicycive Therapeutics,Â Inc.",UNCY,CIK0001766140,USD,357000.0,357000.0,,334000.0,658000.0,3775000.0,,,660921.0,913000.0,913000.0,,1000.0,1000.0,,,,0.001,200000000.0,8771290.0,8771290.0,9000.0,,,3199000.0,,,864000.0,-0.13,294000.0,,286000.0,,,,,,,321000.0,,5115000.0,913000.0,5115000.0,901000.0,,,-1100000.0,-321000.0,,779000.0,-779000.0,,38000.0,,,,0.001,10000000.0,0.0,0.0,10000.0,,,,,,-1100000.0,,493000.0,-7986000.0,23000.0,294000.0,,,,,,,,2631.0,660921.0,,215599.0,,,,4.21,,,-4202000.0,,,,,,30000.0,,6000.0,8771290.0
2021-09-30,2021-11-12,10-Q,"Unicycive Therapeutics,Â Inc.",UNCY,CIK0001766140,USD,49000.0,49000.0,,43000.0,633000.0,32169000.0,,,5606650.0,19782000.0,19782000.0,,18011000.0,18011000.0,,6.0,,0.001,200000000.0,14972552.0,14972552.0,15000.0,,,,,,,-0.37,239000.0,,939000.0,,,,,,,55000.0,,785000.0,19782000.0,785000.0,103000.0,,,-5201000.0,-486000.0,,4715000.0,-4715000.0,,58000.0,,,4784193000.0,0.001,10000000.0,0.0,0.0,1713000.0,,,,,,-5201000.0,,3776000.0,-13187000.0,72000.0,239000.0,,,,4784193.0,,,,504.0,822457.0,6.0,273421.0,,,,4.21,,,18997000.0,,,,,3685000.0,30000.0,22271000.0,14000.0,14167098.0
